LD-2 disclosure · 3rd Quarter - Amendment
CELGENE CORPORATION
Client
- Location
- New Jersey · United States of America
Registrant
- Description
- 8/1/2004
- Location
- Summit, New Jersey, United States of America
Lobbying activities
3 issuesHealth Issues
HR 2841, "FAST Generic Act of 2015", regarding risk evaluation and mitigation strategy. HR 2739/S 1566, "Cancer Drug Coverage Parity Act", regarding all provisions. HR 1600, "Patients Access To Treatments Act", regarding all provisions. S 3056, "CREATES Act of 2016", provisions regarding REMS. Issues related to Medicare Part D/Part B, the Affordable Care Act, Regulation of Non-Biological Complex Drugs, TRICARE, & Step Therapy/Fail First.
LobbyistsALAN EISENBERG · PATRICK GLIHA · MATTHEW SCHUMAKER
TargetedSENATE · HOUSE OF REPRESENTATIVES
Taxation/Internal Revenue Code
Corporate Tax Reform.
LobbyistsALAN EISENBERG · PATRICK GLIHA · MATTHEW SCHUMAKER
TargetedSENATE · HOUSE OF REPRESENTATIVES
Copyright/Patent/Trademark
HR 9, "Innovation Act", provisions regarding patent reform. S 632, "STRONG Patents Act", provisions regarding patent reform.
LobbyistsALAN EISENBERG · PATRICK GLIHA · MATTHEW SCHUMAKER
TargetedSENATE · HOUSE OF REPRESENTATIVES